Sign in
4

Changes in Ownership

HAEMONETICS CORP Filed Acc 0001127602-23-015925

President & CEO gave up 1,586 shares (to pay taxes)

  • President & CEO acquired 18,225 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Simon, Christopher · President & CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-05-15 Grant or award : show line 1 in the form +18,225 222,792 D
2023-05-16 Shares withheld for taxes : show line 2 in the form −1,586 $89.21 $141,487 221,206 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-05-15 Grant or award : show line 3 in the form Non-qualified Stock Option (Right to Buy) +41,177 41,177 D
Loading xslF345X04/form4.xml…